KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) Other Non Operating Income (2018 - 2025)

Historic Other Non Operating Income for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to -$64000.0.

  • ClearPoint Neuro's Other Non Operating Income fell 48181.82% to -$64000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$120000.0, marking a year-over-year decrease of 23333.33%. This contributed to the annual value of -$40000.0 for FY2024, which is 3793.1% down from last year.
  • Latest data reveals that ClearPoint Neuro reported Other Non Operating Income of -$64000.0 as of Q3 2025, which was down 48181.82% from -$52000.0 recorded in Q2 2025.
  • ClearPoint Neuro's Other Non Operating Income's 5-year high stood at $62000.0 during Q3 2021, with a 5-year trough of -$96000.0 in Q2 2021.
  • For the 5-year period, ClearPoint Neuro's Other Non Operating Income averaged around -$14722.2, with its median value being -$9500.0 (2022).
  • In the last 5 years, ClearPoint Neuro's Other Non Operating Income skyrocketed by 66363.64% in 2021 and then crashed by 114000.0% in 2025.
  • Quarter analysis of 5 years shows ClearPoint Neuro's Other Non Operating Income stood at -$3000.0 in 2021, then plummeted by 733.33% to -$25000.0 in 2022, then surged by 84.0% to -$4000.0 in 2023, then crashed by 100.0% to -$8000.0 in 2024, then tumbled by 700.0% to -$64000.0 in 2025.
  • Its Other Non Operating Income was -$64000.0 in Q3 2025, compared to -$52000.0 in Q2 2025 and $4000.0 in Q1 2025.